Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content
Figure 6 | Cell & Bioscience

Figure 6

From: Comparative analysis of the activation of unfolded protein response by spike proteins of severe acute respiratory syndrome coronavirus and human coronavirus HKU1

Figure 6

Mapping of UPR-activating domain in SARS-CoV and HCoV-HKU1 S proteins. (A) Truncated mutants. SARS-CoV (SCV) S protein and its truncated mutants S1 (amino acids 1–770), S2 (amino acids 771–1255), S1-M1 (amino acids 201–770), S1-M2 (amino acids 401–770) and S1-M3 (amino acids 534–770) as well as HCoV-HKU1 S protein and its truncated mutants S1 (amino acids 1–869) and S2 (amino acids 870–1356) were expressed in 293FT cells. (B-E) Luciferase reporter assay. S protein and its truncated mutants in escalating doses were compared for the activity to activate luciferase reporter expression driven by Grp78 and Grp94 promoters.

Back to article page